Cash Flow Statement

Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Non-Current Receivables Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Outstanding Shares Outstanding

Westlake Chemical Partners (WLKP) Shares Issued (2017 - 2019)

Westlake Chemical Partners filings provide 2 years of Shares Issued readings, the most recent being -$255000.0 for Q3 2019.

On a quarterly basis, Shares Issued changed N/A to -$255000.0 in Q3 2019 year-over-year; TTM through Jun 2020 was -$255000.0, a 100.41% decrease, with the full-year FY2019 number at $62.7 million, changed N/A from a year prior.
Shares Issued hit -$255000.0 in Q3 2019 for Westlake Chemical Partners, down from -$18000.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $62.9 million in Q1 2019 to a low of -$255000.0 in Q3 2019.